Logo for ARS Pharmaceuticals Inc

ARS Pharmaceuticals Investor Relations Material

Latest events

Logo for ARS Pharmaceuticals Inc

Q3 2024

ARS Pharmaceuticals
Logo for ARS Pharmaceuticals

Q3 2024

13 Nov, 2024
Logo for ARS Pharmaceuticals

FDA Announcement

12 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from ARS Pharmaceuticals Inc

Access all reports
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for patients and caregivers affected by severe allergic reactions, including anaphylaxis. The company's flagship product in development is Neffy, a needle-free, low-dose intranasal epinephrine nasal spray designed to offer a safe, effective, and user-friendly alternative to traditional injectable epinephrine devices. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.